4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001144204-18-040076
CIK 0001508381other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 1:56 PM ET
Size
6.2 KB
Accession
0001144204-18-040076
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2018-07-24$0.05/sh+43,468,547$2,229,936→ 134,672,664 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (2)
- [F1]Effective as of July 20, 2018, an aggregate amount of $2,006,943 in convertible promissory notes issued to RGD Investissements (the "Notes") converted in accordance with their terms into 43,468,547 shares of the Issuer's common stock. For purposes of the filing of this Form 4, the transaction date is deemed to be July 24, 2018, as that was the date that the Issuer preliminarily determined the number of shares of common stock that the Notes were convertible into in accordance with the terms of the Notes.
- [F2]The conversion price of the Notes was calculated using the VWAP (as defined in the Notes) average of the last 30 days before July 20, 2018. As of the date hereof, the Issuer has not definitively determined the conversion price. In the event that the Issuer definitively determines that the conversion price was lower than $0.0513, the Reporting Person will file an amendment to this Form 4 to reflect the correct conversion price, number of shares acquired upon conversion, and the amount of securities beneficially owned following the reported transaction.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 1:56 PM ET
- Size
- 6.2 KB